Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 371-372

  Furrer, Hansjakob ^a   Malinverni, Raffaele ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MYCOBACTERIOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; INFLAMMATION; NELFINAVIR; PREDNISONE; TUBERCULOSIS;

EID: 0033105750     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00015-7     Document Type: Article

References (4)

1. Dooley D.P., Carpenter J.L., Rademacher S. Adjunctive corticosteroid therapy for tuberculosis a critical reappraisal of the literature . Clin Infect Dis. 25:1997;872-887.
2. Autran B., Carcelain G., Li T.S., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 227:1997;112-116.
3. Race E.M., Adelson-Mitty J., Kriegel G.R., et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet. 351:1998;252-255.
4. Klausner J.D., Makonkawkeyoon S., Akarasewi P., et al. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol. 11:1996;247-257.